{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,7]],"date-time":"2023-10-07T13:12:41Z","timestamp":1696684361591},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2008,11,25]],"date-time":"2008-11-25T00:00:00Z","timestamp":1227571200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Science Inc"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1007\/s11916-008-0071-9","type":"journal-article","created":{"date-parts":[[2008,11,26]],"date-time":"2008-11-26T10:30:59Z","timestamp":1227695459000},"page":"418-422","source":"Crossref","is-referenced-by-count":4,"title":["Pain management in gout"],"prefix":"10.1007","volume":"12","author":[{"given":"Brian S.","family":"Kirby","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan C.","family":"McTigue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. Lawrence","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,11,25]]},"reference":[{"key":"71_CR1","first-page":"15","volume":"12","author":"S. Howe","year":"1995","unstructured":"Howe S, Edwards NL: Controlling hyperuricemia and gout in cardiac transplant recipients. J Musculoskelet Med 1995, 12:15\u201324.","journal-title":"J Musculoskelet Med"},{"key":"71_CR2","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0889-857X(05)70155-1","volume":"26","author":"C. Agudelo","year":"2000","unstructured":"Agudelo C, Wise C: Crystal-associated arthritis in the elderly. Rheum Dis Clin North Am 2000, 26:527\u2013546.","journal-title":"Rheum Dis Clin North Am"},{"key":"71_CR3","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/1529-0131(199805)41:5<778::AID-ART4>3.0.CO;2-V","volume":"41","author":"R.C. Lawrence","year":"1998","unstructured":"Lawrence RC, Helmick CG, Arnett FC, et al.: Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum 1998, 41:778\u2013799.","journal-title":"Arthritis Rheum"},{"key":"71_CR4","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.amjmed.2006.06.040","volume":"120","author":"H.K. Choi","year":"2007","unstructured":"Choi HK, Ford ES: Prevalence of the metabolic syndrome in individuals with hyperuricemia. Am J Med 2007, 120:442\u2013447.","journal-title":"Am J Med"},{"key":"71_CR5","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1136\/bmj.39449.819271.BE","volume":"336","author":"H.K. Choi","year":"2008","unstructured":"Choi HK, Churan G: Soft drinks, fructose consumption, and the risk of gout in men: prospective cohort study. Brit Med J 2008, 336:309\u2013312.","journal-title":"Brit Med J"},{"key":"71_CR6","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S0049-0172(96)80038-2","volume":"25","author":"J.D. Popp","year":"1996","unstructured":"Popp JD, Bidgood WD, Edwards NL: Magnetic resonance imaging of tophaceous gout in the hands and wrists. Semin Arthritis Rheum 1996, 25:282\u2013289.","journal-title":"Semin Arthritis Rheum"},{"key":"71_CR7","first-page":"1888","volume":"34","author":"F. Perez-Ruiz","year":"2007","unstructured":"Perez-Ruiz F, Martin I, Canteli B: Ultrasonographic measurement of tophi as an outcome measure for chronic gout. J Rheumatol 2007, 34:1888\u20131893.","journal-title":"J Rheumatol"},{"key":"71_CR8","doi-asserted-by":"crossref","first-page":"52797","DOI":"10.1074\/jbc.M403823200","volume":"279","author":"M. Jaramillo","year":"2004","unstructured":"Jaramillo M, Godbout M, Naccache PH, et al.: Signaling events involved in macrophage chemokine expression in response to monosodium urate crystals. J Biol Chem 2004, 279:52797\u201352805.","journal-title":"J Biol Chem"},{"key":"71_CR9","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1002\/art.21238","volume":"52","author":"R. Liu-Bryan","year":"2005","unstructured":"Liu-Bryan R, Scott P, Sydlaske A, et al.: Innate immunity conferred by toll-like receptors 2 and 4 and myeloid differentiation factor 88 expression is pivotal to monosodium urate monohydrate crystal-induced inflammation. Arthritis Rheum 2005, 52:2936\u20132946.","journal-title":"Arthritis Rheum"},{"key":"71_CR10","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1185\/03007999109111513","volume":"12","author":"A. Maccagno","year":"1991","unstructured":"Maccagno A, Di Giorgio E, Romanowicz A: Effectiveness of etodolac (\u2019Lodine\u2019) compared with naproxen in patients with acute gout. Curr Med Res Opin 1991, 12:423\u2013429.","journal-title":"Curr Med Res Opin"},{"key":"71_CR11","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/S0196-0644(95)70037-4","volume":"26","author":"M. Shrestha","year":"1995","unstructured":"Shrestha M, Morgan DL, Moreden JM, et al.: Randomized double-blind comparison of the analgesic efficacy of intramuscular ketorolac and oral indomethacin in the treatment of acute gouty arthritis. Ann Emerg Med 1995, 26:682\u2013686.","journal-title":"Ann Emerg Med"},{"key":"71_CR12","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1093\/rheumatology\/kem090","volume":"46","author":"R.E. Willburger","year":"2007","unstructured":"Willburger RE, Mysler E, Derbot J, et al.: Lumiracoxib 400 mg once daily is comparable to indomethacin 50 mg three times daily for the treatment of acute flares of gout. Rheumatol (Oxford) 2007, 46:1126\u20131132.","journal-title":"Rheumatol (Oxford)"},{"key":"71_CR13","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1185\/030079907X210750","volume":"23","author":"S. Navarra","year":"2007","unstructured":"Navarra S, Rubin BR, Yu Q, et al.: Association of baseline disease and patient characteristics with response to etoricoxib and indomethacin for acute gout. Curr Med Res Opin 2007, 23:1685\u20131691.","journal-title":"Curr Med Res Opin"},{"key":"71_CR14","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.2165\/00003495-200464210-00003","volume":"64","author":"N. Schlesinger","year":"2004","unstructured":"Schlesinger N: Management of acute and chronic gouty arthritis. Drugs 2004, 64:2399\u20132416.","journal-title":"Drugs"},{"key":"71_CR15","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/1529-0131(195910)2:5<389::AID-ART1780020503>3.0.CO;2-W","volume":"2","author":"S.L. Wallace","year":"1959","unstructured":"Wallace SL: Colchicine analogs in the treatment of acute gout. Arthritis Rheum 1959, 2:389\u2013394.","journal-title":"Arthritis Rheum"},{"key":"71_CR16","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1445-5994.1987.tb01232.x","volume":"17","author":"M.J. Ahern","year":"1987","unstructured":"Ahern MJ, Reid C, Gordon TP: Does colchicine work? Results of the first controlled study in gout. Aust N Z J Med 1987, 17:301\u2013304.","journal-title":"Aust N Z J Med"},{"key":"71_CR17","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1136\/ard.2006.055269","volume":"65","author":"W. Zhang","year":"2006","unstructured":"Zhang W, Doherty M, Bardin T, et al.: EULAR evidence based recommendations for gout. Part II: management. Report of a task force of the EULAR Study Committee for Interventional Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2006, 65:1312\u20131324.","journal-title":"Ann Rheum Dis"},{"key":"71_CR18","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1056\/NEJM198706183162502","volume":"316","author":"R.W. Kuncl","year":"1987","unstructured":"Kuncl RW, Duncan G, Watson D, et al.: Colchicine myopathy and neuropathy. N Eng J Med 1987, 316:1562\u20131568.","journal-title":"N Eng J Med"},{"key":"71_CR19","first-page":"1325","volume":"21","author":"L.B. Siegal","year":"1994","unstructured":"Siegal LB, Alloway JA, Nashel DJ: Comparison of adrenocorticotropic hormone and triamcinolone acetate in the treatment of acute gouty arthritis. J Rheumatol 1994, 21:1325\u20131337.","journal-title":"J Rheumatol"},{"key":"71_CR20","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1002\/art.10526","volume":"46","author":"S.J. Getting","year":"2002","unstructured":"Getting SJ, Christian HC, Flower RJ, Perretti M: Activation of melanocortin type 3 receptor as a molecular mechanism for adrenocorticotropic hormone efficacy in gouty arthritis. Arthritis Rheum 2002, 46:2765\u20132775.","journal-title":"Arthritis Rheum"},{"key":"71_CR21","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/ncprheum0350","volume":"2","author":"H.M. Hoffman","year":"2006","unstructured":"Hoffman HM, Firestein GS: Anakinra for the treatment of neonatal-onset multisystem inflammatory diseases. Nat Clin Pract Rheumatol 2006, 2:646\u2013647.","journal-title":"Nat Clin Pract Rheumatol"},{"key":"71_CR22","doi-asserted-by":"crossref","first-page":"R28","DOI":"10.1186\/ar2143","volume":"9","author":"A. So","year":"2007","unstructured":"So A, De Smedt T, Revaz S, Tschopp J: A pilot study of IL-1 inhibition by anakinra in acute gout. Arthritis Res Ther 2007, 9:R28.","journal-title":"Arthritis Res Ther"},{"key":"71_CR23","first-page":"2429","volume":"31","author":"G.C. Borstad","year":"2004","unstructured":"Borstad GC, Bryant LR, Abel MP, et al.: Colchicine for prophylaxis of acute flares when initiating allopurinol for chronic gouty arthritis. J Rheumatol 2004, 31:2429\u20132439.","journal-title":"J Rheumatol"},{"key":"71_CR24","volume-title":"Arthritis and Allied Conditions","author":"P. Hahn","year":"2004","unstructured":"Hahn P, Edwards NL: Management of hyperuricemia. In Arthritis and Allied Conditions, 15th edn. Edited by Koopman WJ. Baltimore: Williams and Wilkins; 2004.","edition":"15th edn"},{"key":"71_CR25","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1136\/ard.25.Suppl_6.623","volume":"25","author":"J.T. Scott","year":"1966","unstructured":"Scott JT: Comparison of allopurinol and probenecid. Ann Rheum Dis 1966, 25:623\u2013626.","journal-title":"Ann Rheum Dis"},{"key":"71_CR26","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0002-9343(84)90743-5","volume":"76","author":"K.R. Hande","year":"1984","unstructured":"Hande KR, Noone RM, Stone WJ: Severe allopurinol toxicity. Description and guidelines for prevention in patients with renal insufficiency. Am J Med 1984, 76:47\u201356.","journal-title":"Am J Med"},{"key":"71_CR27","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/00124743-199904000-00003","volume":"5","author":"F.C.M. Perez-Ruiz","year":"1999","unstructured":"Perez-Ruiz FCM, Calabozo M, Fernandez-Lopez MJ, et al.: Treatment of chronic gout in patients with renal function impairment. An open, randomized, actively controlled study. J Clin Rheumatol 1999; 5:49\u201355.","journal-title":"J Clin Rheumatol"},{"key":"71_CR28","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1136\/ard.60.10.981","volume":"60","author":"J. Vazquez-Mellado","year":"2001","unstructured":"Vazquez-Mellado J, Morales EM, Pacheco-Tena C, et al.: Relationship between adverse events associated with allopurinol and renal function in patients with gout. Ann Rheum Dis, 2001, 60:981\u2013983.","journal-title":"Ann Rheum Dis"},{"key":"71_CR29","unstructured":"The Gout & Uric Acid Education Society. Available at http:\/\/www.gouteducation.org . Accessed June 2008."}],"container-title":["Current Pain and Headache Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-008-0071-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11916-008-0071-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-008-0071-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T20:38:23Z","timestamp":1559421503000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11916-008-0071-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11,25]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["71"],"URL":"https:\/\/doi.org\/10.1007\/s11916-008-0071-9","relation":{},"ISSN":["1531-3433","1534-3081"],"issn-type":[{"value":"1531-3433","type":"print"},{"value":"1534-3081","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,11,25]]}}}